Skip to main content

Femto Technologies Inc.

corporate_fare Company Profile

Femto Technologies Inc.

FMTOF·OTC·Technology·CIK 0001888151

Zigi Carmel Initiatives & Investments Ltd. develops and sells a unique medical device and proprietary software, and also develops, markets, and sells client relationship management (CRM) software. All of the company's business operations and revenues are currently located in Israel. The company's Sensera Business involves the Sensera device, a patent-pending device that, combined with proprietary AI software, regulates the flow of lubricants and oils into the soft tissues of the female sexual organs. The company completed its acquisition of Israeli-based Zigi Carmel Initiatives & Investments Ltd. on September 22, 2022, through which it owns the Sensera device. The CRM Software Business is managed by BYND-Beyond Solutions Ltd. (Israel), a wholly-owned subsidiary. This subsidiary has developed the Benefit CRM Software, which helps small and medium-sized businesses optimize daily activities such as sales management, personnel management, marketing, call center operations, and asset management. The company previously had a Medical Cannabis Business, where BYND Israel aimed to leverage the construction and operation of a Cannabis Farm to develop a New Cannabis CRM Platform for the medical cannabis sector. However, the company's board of directors decided to suspend activities related to the construction of the cannabis growing facility.

Femto Technologies Inc. (OTC:FMTOF) is a publicly traded company in the Technology sector. Wiseek has independently scored 1 item for FMTOF at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-03-27, rated 10/10. Recent SEC coverage for FMTOF spans 6-K.

Recent high-impact activity:

  • Femto Technologies to Acquire 40% Stake in AI Software Company Gilad for $1.35M, a Transformational Bet for the Micro-Cap Firm

Short Interest & Short Volume

16.38 days to cover

FINRA reported short interest of 639 shares in FMTOF as of the October 30, 2026 settlement, a 7.3% decrease from the prior period — about 16.4 days to cover at its recent average daily volume. On November 19, 2026, 35.6% of FMTOF volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)639 shares as of October 30, 2026
Change vs prior period▼ 7.3%
Days to cover16.38 at avg daily volume of 39
Daily short volume (FINRA facilities)35.6% of 2,809 shares on November 19, 2026

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

FMTOF files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$0.3979 -20.42% today
52-week range · as of 2026-03-27 $0.2503 – $2424975
Market cap
$412.93K
Volume
2.8K (1.4× avg)
3-mo avg 2K
Live data · 2026-11-22 12:42 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed FMTOF - Latest Insights

FMTOF
Mar 27, 2026, 5:20 PM EDT
Filing Type: 6-K
Importance Score:
10
Price at Filing: $0.700
Real-time Price: $0.3979 info
Change: -$0.3021 (-43%) info
Market Cap: $412.93K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets